The global Molecular Infectious Disease Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Products and Services (Reagents & Kits, Instruments, Services & Software), By Type (Multiplex Testing, Singleplex Testing), By Test Type (Laboratory Tests, Point Of Care Tests), By Disease (Respiratory Infectious Diseases, Gastrointestinal Infectious Diseases, Sexually Transmitted Diseases, Hospital-Acquired Infections, Vaginitis, Meningitis, Vector-Borne Diseases, Others), By Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Others).
The Molecular Infectious Disease Testing Market is expanding rapidly, driven by the need for accurate, rapid diagnostics in the wake of global health threats. PCR-based tests, next-generation sequencing (NGS), and CRISPR-based diagnostics are revolutionizing pathogen detection and disease surveillance. The rise of point-of-care molecular testing is improving accessibility in both clinical and remote settings. Government initiatives and investments in pandemic preparedness are further boosting market growth. However, challenges such as high test costs, sample contamination risks, and regulatory hurdles persist. Companies integrating AI-driven diagnostics and portable testing solutions are expected to gain a competitive edge in this evolving market.
The market report analyses the leading companies in the industry including Abbott, Advanced Molecular Diagnostics, altona Diagnostics GmbH, BD, bioMérieux, Bruker, Co-Diagnostics Inc, Danaher, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, GeneFirst Ltd, geneOmbio Technologies, Genetic Signatures, Grifols, S.A., Hologic Inc, Molbio Diagnostics Ltd, QIAGEN, QuidelOrtho Corp, Revvity, Savyon Diagnostics, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Uniogen Oy, Vela Diagnostics, and others.
The molecular infectious disease testing market is witnessing a shift toward point-of-care (POC) and rapid diagnostic solutions. Technologies such as CRISPR-based diagnostics and microfluidic devices are enabling quicker, more accurate detection of infectious diseases, reducing reliance on centralized laboratories. This trend is particularly crucial in managing outbreaks and improving access to diagnostics in remote and underserved regions, where timely disease detection can significantly impact patient outcomes.
The rising incidence of infectious diseases such as COVID-19, influenza, tuberculosis, and antibiotic-resistant bacteria is a key driver for the molecular infectious disease testing market. Governments and healthcare organizations are investing in advanced molecular diagnostics to strengthen disease surveillance, improve outbreak preparedness, and enhance pandemic response capabilities. The need for rapid, highly sensitive testing methods is fueling the adoption of polymerase chain reaction (PCR), next-generation sequencing (NGS), and isothermal amplification techniques.
A major opportunity lies in the integration of AI and machine learning to enhance the accuracy and efficiency of molecular diagnostics. AI-driven diagnostic tools can analyze vast datasets, identify disease patterns, and provide predictive insights for early disease detection and personalized treatment plans. Companies developing AI-powered molecular diagnostic platforms can offer faster, more reliable testing solutions, revolutionizing infectious disease management and patient care.
The Polymerase Chain Reaction (PCR) segment is the largest in the molecular infectious disease testing market due to its widespread adoption as the gold standard for detecting infectious diseases with high accuracy, sensitivity, and rapid turnaround time. PCR technology is extensively used in diagnosing viral, bacterial, and fungal infections, including COVID-19, HIV, tuberculosis, and influenza. Its dominance is further driven by continuous advancements, automation, and integration with real-time and digital PCR techniques, making it a preferred choice in hospitals, diagnostic laboratories, and research institutions. Additionally, increasing global healthcare investments and government initiatives supporting infectious disease surveillance bolster its market share.
The Reagents & Kits segment is expected to be the fastest-growing over the forecast period to 2034 due to the increasing demand for rapid, accurate, and cost-effective diagnostic solutions for infectious diseases. The rising prevalence of viral and bacterial infections, including COVID-19, influenza, and sexually transmitted diseases, has led to a surge in the adoption of molecular testing kits. Additionally, continuous advancements in nucleic acid amplification technologies, growing preference for point-of-care testing, and the expansion of decentralized diagnostic centers further accelerate the growth of this segment. Moreover, the recurring nature of reagent purchases compared to one-time instrument investments sustains strong market demand.
The Laboratory Tests segment is the largest in the Molecular Infectious Disease Testing Market due to the high accuracy, reliability, and scalability of these tests in detecting a wide range of infectious diseases. Hospitals, diagnostic laboratories, and research institutions heavily rely on laboratory-based molecular testing, such as PCR and DNA sequencing, for comprehensive disease diagnosis and epidemiological studies. Additionally, centralized laboratory facilities can handle high sample volumes, making them the preferred choice for large-scale disease surveillance and outbreak management. The continued advancements in automation, integration of AI-driven analysis, and expansion of molecular diagnostic capabilities further solidify laboratory testing as the dominant segment.
The Sexually Transmitted Diseases (STDs) segment is expected to be the fastest growing in the Molecular Infectious Disease Testing Market over the forecast period to 2034. This growth is driven by the rising global prevalence of STDs such as HIV, chlamydia, gonorrhea, and syphilis, coupled with increasing awareness and government initiatives for early detection and treatment. Advances in molecular diagnostic technologies, such as rapid PCR-based tests and point-of-care molecular testing, are improving accessibility and accuracy, further fueling market expansion. Additionally, the growing emphasis on routine screening, increasing investments in public health programs, and demand for at-home STD testing solutions are accelerating adoption rates, making this the fastest-growing segment.
|
Parameter |
Details |
|
Market Size (2025) |
$10.3 Billion |
|
Market Size (2034) |
$30.5 Billion |
|
Market Growth Rate |
12.8% |
|
Segments |
By Products and Services (Reagents & Kits, Instruments, Services & Software), By Type (Multiplex Testing, Singleplex Testing), By Test Type (Laboratory Tests, Point Of Care Tests), By Disease (Respiratory Infectious Diseases, Gastrointestinal Infectious Diseases, Sexually Transmitted Diseases, Hospital-Acquired Infections, Vaginitis, Meningitis, Vector-Borne Diseases, Others), By Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
Abbott, Advanced Molecular Diagnostics, altona Diagnostics GmbH, BD, bioMérieux, Bruker, Co-Diagnostics Inc, Danaher, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, GeneFirst Ltd, geneOmbio Technologies, Genetic Signatures, Grifols, S.A., Hologic Inc, Molbio Diagnostics Ltd, QIAGEN, QuidelOrtho Corp, Revvity, Savyon Diagnostics, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Uniogen Oy, Vela Diagnostics |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Products and Services
Reagents & Kits
Instruments
Services & Software
By Type
Multiplex Testing
Singleplex Testing
By Test Type
Laboratory Tests
Point Of Care Tests
By Disease
Respiratory Infectious Diseases
Gastrointestinal Infectious Diseases
Sexually Transmitted Diseases
Hospital-Acquired Infections
Vaginitis
Meningitis
Vector-Borne Diseases
Others
By Technology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-Generation Sequencing
In Situ Hybridization
DNA Microarrays
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Advanced Molecular Diagnostics
altona Diagnostics GmbH
BD
bioMérieux
Bruker
Co-Diagnostics Inc
Danaher
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
GeneFirst Ltd
geneOmbio Technologies
Genetic Signatures
Grifols, S.A.
Hologic Inc
Molbio Diagnostics Ltd
QIAGEN
QuidelOrtho Corp
Revvity
Savyon Diagnostics
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Uniogen Oy
Vela Diagnostics
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
Market Segments
Companies Profiled
Research Methodology
Bottom-Up Method
Top-Down Method
Data Triangulation
Forecast Methodology
Data Sources
USDA Proprietary Databases
External Sources
Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Nanocoatings Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Nanocoatings Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Nanocoatings Market Size by Segments, 2018- 2024
Key Statistics, 2024
Nanocoatings Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Nanocoatings Types, 2018- 2024
Nanocoatings Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Nanocoatings Applications, 2018- 2024
8. Nanocoatings Market Size Outlook by Segments, 2024- 2034
By Products and Services
Reagents & Kits
Instruments
Services & Software
By Type
Multiplex Testing
Singleplex Testing
By Test Type
Laboratory Tests
Point Of Care Tests
By Disease
Respiratory Infectious Diseases
Gastrointestinal Infectious Diseases
Sexually Transmitted Diseases
Hospital-Acquired Infections
Vaginitis
Meningitis
Vector-Borne Diseases
Others
By Technology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-Generation Sequencing
In Situ Hybridization
DNA Microarrays
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others
9. Nanocoatings Market Size Outlook by Region
North America
Key Market Dynamics
North America Nanocoatings Market Size Outlook by Type, USD Million, 2021-2034
North America Nanocoatings Market Size Outlook by Application, USD Million, 2021-2034
North America Nanocoatings Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Nanocoatings Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Nanocoatings Market Size Outlook by Type, USD Million, 2021-2034
Europe Nanocoatings Market Size Outlook by Application, USD Million, 2021-2034
Europe Nanocoatings Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Nanocoatings Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Nanocoatings Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Nanocoatings Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Nanocoatings Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Nanocoatings Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Nanocoatings Market Size Outlook by Type, USD Million, 2021-2034
South America Nanocoatings Market Size Outlook by Application, USD Million, 2021-2034
South America Nanocoatings Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Nanocoatings Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Nanocoatings Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Nanocoatings Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Nanocoatings Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Nanocoatings Market Size Outlook by Country, USD Million, 2021-2034
10. United States Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Nanocoatings Market Size Outlook by Type, 2021- 2034
United States Nanocoatings Market Size Outlook by Application, 2021- 2034
United States Nanocoatings Market Size Outlook by End-User, 2021- 2034
11. Canada Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Nanocoatings Market Size Outlook by Type, 2021- 2034
Canada Nanocoatings Market Size Outlook by Application, 2021- 2034
Canada Nanocoatings Market Size Outlook by End-User, 2021- 2034
12. Mexico Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Nanocoatings Market Size Outlook by Type, 2021- 2034
Mexico Nanocoatings Market Size Outlook by Application, 2021- 2034
Mexico Nanocoatings Market Size Outlook by End-User, 2021- 2034
13. Germany Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Nanocoatings Market Size Outlook by Type, 2021- 2034
Germany Nanocoatings Market Size Outlook by Application, 2021- 2034
Germany Nanocoatings Market Size Outlook by End-User, 2021- 2034
14. France Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
France Nanocoatings Market Size Outlook by Type, 2021- 2034
France Nanocoatings Market Size Outlook by Application, 2021- 2034
France Nanocoatings Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Nanocoatings Market Size Outlook by Type, 2021- 2034
United Kingdom Nanocoatings Market Size Outlook by Application, 2021- 2034
United Kingdom Nanocoatings Market Size Outlook by End-User, 2021- 2034
16. Spain Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Nanocoatings Market Size Outlook by Type, 2021- 2034
Spain Nanocoatings Market Size Outlook by Application, 2021- 2034
Spain Nanocoatings Market Size Outlook by End-User, 2021- 2034
17. Italy Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Nanocoatings Market Size Outlook by Type, 2021- 2034
Italy Nanocoatings Market Size Outlook by Application, 2021- 2034
Italy Nanocoatings Market Size Outlook by End-User, 2021- 2034
18. Benelux Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Nanocoatings Market Size Outlook by Type, 2021- 2034
Benelux Nanocoatings Market Size Outlook by Application, 2021- 2034
Benelux Nanocoatings Market Size Outlook by End-User, 2021- 2034
19. Nordic Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Nanocoatings Market Size Outlook by Type, 2021- 2034
Nordic Nanocoatings Market Size Outlook by Application, 2021- 2034
Nordic Nanocoatings Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Nanocoatings Market Size Outlook by Type, 2021- 2034
Rest of Europe Nanocoatings Market Size Outlook by Application, 2021- 2034
Rest of Europe Nanocoatings Market Size Outlook by End-User, 2021- 2034
21. China Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
China Nanocoatings Market Size Outlook by Type, 2021- 2034
China Nanocoatings Market Size Outlook by Application, 2021- 2034
China Nanocoatings Market Size Outlook by End-User, 2021- 2034
22. India Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
India Nanocoatings Market Size Outlook by Type, 2021- 2034
India Nanocoatings Market Size Outlook by Application, 2021- 2034
India Nanocoatings Market Size Outlook by End-User, 2021- 2034
23. Japan Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Nanocoatings Market Size Outlook by Type, 2021- 2034
Japan Nanocoatings Market Size Outlook by Application, 2021- 2034
Japan Nanocoatings Market Size Outlook by End-User, 2021- 2034
24. South Korea Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Nanocoatings Market Size Outlook by Type, 2021- 2034
South Korea Nanocoatings Market Size Outlook by Application, 2021- 2034
South Korea Nanocoatings Market Size Outlook by End-User, 2021- 2034
25. Australia Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Nanocoatings Market Size Outlook by Type, 2021- 2034
Australia Nanocoatings Market Size Outlook by Application, 2021- 2034
Australia Nanocoatings Market Size Outlook by End-User, 2021- 2034
26. South East Asia Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Nanocoatings Market Size Outlook by Type, 2021- 2034
South East Asia Nanocoatings Market Size Outlook by Application, 2021- 2034
South East Asia Nanocoatings Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Nanocoatings Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Nanocoatings Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Nanocoatings Market Size Outlook by End-User, 2021- 2034
28. Brazil Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Nanocoatings Market Size Outlook by Type, 2021- 2034
Brazil Nanocoatings Market Size Outlook by Application, 2021- 2034
Brazil Nanocoatings Market Size Outlook by End-User, 2021- 2034
29. Argentina Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Nanocoatings Market Size Outlook by Type, 2021- 2034
Argentina Nanocoatings Market Size Outlook by Application, 2021- 2034
Argentina Nanocoatings Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Nanocoatings Market Size Outlook by Type, 2021- 2034
Rest of South America Nanocoatings Market Size Outlook by Application, 2021- 2034
Rest of South America Nanocoatings Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Nanocoatings Market Size Outlook by Type, 2021- 2034
United Arab Emirates Nanocoatings Market Size Outlook by Application, 2021- 2034
United Arab Emirates Nanocoatings Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Nanocoatings Market Size Outlook by Type, 2021- 2034
Saudi Arabia Nanocoatings Market Size Outlook by Application, 2021- 2034
Saudi Arabia Nanocoatings Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Nanocoatings Market Size Outlook by Type, 2021- 2034
Rest of Middle East Nanocoatings Market Size Outlook by Application, 2021- 2034
Rest of Middle East Nanocoatings Market Size Outlook by End-User, 2021- 2034
34. South Africa Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Nanocoatings Market Size Outlook by Type, 2021- 2034
South Africa Nanocoatings Market Size Outlook by Application, 2021- 2034
South Africa Nanocoatings Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Nanocoatings Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Nanocoatings Market Size Outlook by Type, 2021- 2034
Rest of Africa Nanocoatings Market Size Outlook by Application, 2021- 2034
Rest of Africa Nanocoatings Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Abbott
Advanced Molecular Diagnostics
altona Diagnostics GmbH
BD
bioMérieux
Bruker
Co-Diagnostics Inc
Danaher
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
GeneFirst Ltd
geneOmbio Technologies
Genetic Signatures
Grifols, S.A.
Hologic Inc
Molbio Diagnostics Ltd
QIAGEN
QuidelOrtho Corp
Revvity
Savyon Diagnostics
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Uniogen Oy
Vela Diagnostics
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Products and Services
Reagents & Kits
Instruments
Services & Software
By Type
Multiplex Testing
Singleplex Testing
By Test Type
Laboratory Tests
Point Of Care Tests
By Disease
Respiratory Infectious Diseases
Gastrointestinal Infectious Diseases
Sexually Transmitted Diseases
Hospital-Acquired Infections
Vaginitis
Meningitis
Vector-Borne Diseases
Others
By Technology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-Generation Sequencing
In Situ Hybridization
DNA Microarrays
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Others
The Global Molecular Infectious Disease Testing Market Size is estimated at $10.3 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.8% to reach $30.5 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Advanced Molecular Diagnostics, altona Diagnostics GmbH, BD, bioMérieux, Bruker, Co-Diagnostics Inc, Danaher, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, GeneFirst Ltd, geneOmbio Technologies, Genetic Signatures, Grifols, S.A., Hologic Inc, Molbio Diagnostics Ltd, QIAGEN, QuidelOrtho Corp, Revvity, Savyon Diagnostics, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Uniogen Oy, Vela Diagnostics
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume